CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −4,113 | $6.32 | $26K | 117,540 |
| 2023-03-03 | Polymeropoulos Mihael Hristos President and CEO | Sale | −22,538 | $6.25 | $141K | 1,476,902 |
| 2023-03-03 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −5,968 | $6.28 | $37K | 138,926 |
| 2023-03-03 | Birznieks Gunther SVP, Business Development | Sale | −8,268 | $6.26 | $52K | 205,980 |
| 2023-03-02 | Williams Timothy SVP & General Counsel | Sale | −8,437 | $6.24 | $53K | 111,814 |
| 2023-03-02 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −7,720 | $6.23 | $48K | 121,653 |
| 2023-03-02 | Polymeropoulos Mihael Hristos President and CEO | Sale | −22,426 | $6.23 | $140K | 1,499,440 |
| 2023-03-02 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −7,966 | $6.26 | $50K | 144,894 |
| 2023-03-02 | Birznieks Gunther SVP, Business Development | Sale | −8,509 | $6.20 | $53K | 214,248 |
| 2023-02-16 | Williams Timothy SVP & General Counsel | Grant or award | +32,700 | 120,251 | ||
| 2023-02-16 | Williams Timothy SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2023-02-16 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award | +32,700 | 129,373 | ||
| 2023-02-16 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2023-02-16 | Polymeropoulos Mihael Hristos President and CEO | Grant or award | +115,000 | 1,521,866 | ||
| 2023-02-16 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2023-02-16 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award | +32,700 | 152,860 | ||
| 2023-02-16 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2023-02-16 | Birznieks Gunther SVP, Business Development | Grant or award | +32,700 | 222,757 | ||
| 2023-02-16 | Birznieks Gunther SVP, Business Development | Grant or award · Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2022-12-15 | Williams Timothy SVP & General Counsel | Sale | −8,000 | $7.01 | $56K | 87,551 |
Page 6 of 8 · 153 trades